Castle Biosciences, Inc. Profile Avatar - Palmy Investing

Castle Biosciences, Inc.

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify th…

Medical - Diagnostics & Research
US, Friendswood [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Castle Biosciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of CSTL's Analysis
CIK: 1447362 CUSIP: 14843C105 ISIN: US14843C1053 LEI: - UEI: -
Secondary Listings
CSTL has no secondary listings inside our databases.